Thus, in solid colon tumors and soft tissue sarcoma, PLCG2 gene expression positively correlates with immune cell infiltration into the tumor microenvironment and favorable prognosis [68], while PLCG2 gene mutations produce resistance of some tumors to chemotherapy. The gene discussed is PLCG2; the disease is neoplasm.